July 12, 2014 8:47 PM ET

Biotechnology

Company Overview of MedImmune Oncology Inc.

Company Overview

MedImmune Oncology Inc., a pharmaceutical company, engages in the development and commercialization of products for patients with cancer and acquired immune deficiency syndrome. MedImmune Oncology Inc. was formerly known as U.S. Bioscience, Inc. As a result of acquisition of U.S. Bioscience, Inc. by MedImmune, LLC, U.S. Bioscience, Inc. name was changed. The company was founded in 1987 and is based in West Conshohocken, Pennsylvania. As of November 23, 1999, MedImmune Oncology Inc. operates as a subsidiary of MedImmune, LLC.

100 Front Street

One Tower Bridge

Suite 400

West Conshohocken, PA 19428

United States

Founded in 1987

148 Employees

Phone:

610-832-0570

Key Executives for MedImmune Oncology Inc.

Chief Financial Officer
Age: 71
Executive Vice President
Age: 59
Executive Vice President - Worldwide Clinical Research
Age: 56
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
AnaptysBio, Inc. United States
Applied Molecular Evolution, Inc. United States
Serometrix, LLC United States
BioCritica, Inc. United States
EcoChoice Protein Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MedImmune Oncology Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.